HomeProductsBioactive CompoundsCytoskeletonFAKGsk-2256098
Chemical structure of CAS 1224887-10-8

Gsk-2256098

CAS No.1224887-10-8
MDL No.MFCD30502650
MFC20H23ClN6O2
MW414.90
InChI KeyBVAHPPKGOOJSPU-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1224887-10-8
Product NameGsk-2256098

Biological Targets

PTK2

Associated Conditions

pulmonary arterial hypertension·cancer·intracranial meningioma·neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

FAK signaling in human cancer as a target for therapeutics.

Pharmacology & therapeutics • Vol. 146 • 2015
PMID: 25316657DOI: 10.1016/j.pharmthera.2014.10.001

A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.

Cell cycle (Georgetown, Tex.) • Vol. 13, Issue 19 • 2014
PMID: 25486573PMC: PMC4615113DOI: 10.4161/15384101.2014.949550

Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.

Anti-cancer agents in medicinal chemistry • Vol. 11, Issue 7 • 2011
PMID: 21787277DOI: 10.2174/187152011796817727

Design and testing of replacement prostheses.

Proceedings of the Royal Society of London. Series B, Biological sciences • Vol. 192, Issue 1107 • 1976
PMID: 3786DOI: 10.1098/rspb.1976.0005

Documentation